U.S. FDA advisers back Pfizer arthritis drug

SILVER SPRING, Maryland (Reuters) - Pfizer Inc won support from a U.S. advisory panel on Wednesday for its arthritis drug, which the world's top drugmaker hopes will give it a major boost after a wave…
Read the full story: Reuters: Health News